Yangyi Bao
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 10
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 2
- Lung Cancer Research Studies 1
-
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 5
- Co-authors
- Qiao Li (6 shared papers)Xiang Sun (3 shared papers)Alfred E. Chang (5 shared papers)Lin Yang (3 shared papers)Fu Dai (4 shared papers)Yi Wang (3 shared papers)Shiang Huang (3 shared papers)Xiaowen Tang (2 shared papers)
- Journals
- Cancer Research (3 papers)Oncotarget (2 papers)International Journal of Nanomedicine (1 paper)Cell chemical biology (1 paper)Cancer Medicine (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yangyi Bao
17 papers receiving 350 citations
Peers
Comparison fields: 5 of 45
- Immunology 203
- Oncology 212
- Biotechnology 30
- Radiology, Nuclear Medicine and Imaging 43
- Cancer Research 21
Countries citing papers authored by Yangyi Bao
This map shows the geographic impact of Yangyi Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyi Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyi Bao more than expected).
Fields of papers citing papers by Yangyi Bao
This network shows the impact of papers produced by Yangyi Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyi Bao. The network helps show where Yangyi Bao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangyi Bao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 87 | |
| 2 | 2016 | 68 | |
| 3 | 2017 | 56 | |
| 4 | 2017 | 38 | |
| 5 | 2016 | 28 | |
| 6 | 2019 | 18 | |
| 7 | 2016 | 13 | |
| 8 | 2021 | 12 | |
| 9 | 2018 | 11 | |
| 10 | 2015 | 6 | |
| 11 | 2017 | 4 | |
| 12 | 2019 | 4 | |
| 13 | 2017 | 3 | |
| 14 | [miR-181b-5p promotes cell proliferation and induces apoptosis in human acute myeloid leukemia by targeting PAX9]. | 2023 | 2 |
| 15 | Clinical research of advanced non-small cell lung cancer patients treated with CIK cell combined with chemotherapy | 2012 | 1 |
| 16 | 2015 | 1 | |
| 17 | 2015 | 1 |
About Yangyi Bao
Yangyi Bao is a scholar working on Oncology, Immunology, Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 353 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Cells and Metastasis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Lung Cancer Research Studies (1 paper) and Synthesis and Characterization of Heterocyclic Compounds (1 paper). The work is most often cited by research in Immunology (203 citations), Oncology (212 citations), Biotechnology (30 citations), Radiology, Nuclear Medicine and Imaging (43 citations) and Cancer Research (21 citations). Yangyi Bao has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Qiao Li, Xiang Sun, Alfred E. Chang, Lin Yang, Fu Dai, Yi Wang, Shiang Huang, Xiaowen Tang, Xuejun Zhu and Lin Lü. Their work appears in journals such as Cancer Research, Oncotarget, International Journal of Nanomedicine, Cell chemical biology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.